Brokerages Set Autolus Therapeutics plc (NASDAQ:AUTL) Price Target at $9.32
Shares of Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have updated their coverage on […]
Shares of Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have updated their coverage on […]
